Vitamin E in the treatment of tardive dyskinesia: a double-blind placebo-controlled study.
The authors compared vitamin E with placebo in a double-blind randomized crossover study of 27 patients with tardive dyskinesia. Each treatment period lasted for 6 weeks. Vitamin E showed no differences from placebo in the treatment of tardive dyskinesia.
Centre de recherche Université Laval Robert-Giffard, Department of Psychiatry, Laval University, Beauport, Quebec, Canada.
C L
CL
Shriqui
J
J
Bradwejn
L
L
Annable
B D
BD
Jones
D000293:Adolescent; D000328:Adult; D000368:Aged; D014150:Antipsychotic Agents / Q000009:adverse effects; D001714:Bipolar Disorder / Q000188:drug therapy; D004311:Double-Blind Method; D004409:Dyskinesia, Drug-Induced / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010808:Physical Examination; D010919:Placebos; D012559:Schizophrenia / Q000188:drug therapy; D014810:Vitamin E / Q000627:therapeutic use*
D014150:Antipsychotic Agents; D010919:Placebos; D014810:Vitamin E